The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release

Serena C Hedgepeth1, M Iveth Garcia1, Larry E Wagner2

  • 1From the Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, Texas 77030, the Cell Biology Graduate Program and.

Insights

The tumor suppressor BRCA1 binds to the inositol 1,4,5-trisphosphate receptor (IP3R), sensitizing it to calcium release. This interaction explains how BRCA1 promotes apoptosis, a key process in cell death regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The inositol 1,4,5-trisphosphate receptor (IP3R) is a critical calcium channel in the endoplasmic reticulum (ER).
  • IP3R-mediated calcium release regulates vital cellular processes, including apoptosis.
  • Protein-protein interactions, particularly with tumor suppressors, modulate IP3R activity and cell death.

Purpose of the Study:

  • To investigate the interaction between the tumor suppressor BRCA1 and the IP3R.
  • To elucidate the functional consequences of BRCA1 binding to IP3R in the context of apoptosis.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Biochemical assays to assess IP3R sensitivity to IP3 upon BRCA1 binding.
  • Cellular localization studies to track BRCA1 recruitment to the ER during apoptosis.

Main Results:

  • BRCA1 directly binds to the IP3R.
  • BRCA1 binding sensitizes the IP3R to its ligand, IP3, enhancing calcium release.
  • BRCA1 is recruited to the ER during apoptosis in an IP3R-dependent manner.
  • A constitutive pool of BRCA1 is associated with the ER, potentially via lipid binding by the BRCA1 C-terminal domain.

Conclusions:

  • BRCA1 acts as a proapoptotic protein by directly modulating IP3R calcium channel activity.
  • The interaction between BRCA1 and IP3R provides a mechanistic link for BRCA1's role in apoptosis.
  • Novel lipid-binding activity of BRCA1 may mediate its constitutive ER localization.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K